AMT-130 at Four Years: Hopeful Signs, Complex Controls
uniQure reports that after 4 years, people given high-dose AMT-130 continue to show signs of slower HD progression, providing hope for their recent regulatory submission. But the new analyses are nuanced. We unpack the hopeful, but complex results. Read more
September 2026: This month in Huntington’s disease research
September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, and encouraging SKY-0515 data, we round up a busy month in Huntington’s disease research. Read more
Highlighting Mental Health Disparities in Indigenous Communities Affected by Huntington’s Disease
⏱️12 min read | Unique research highlights an overlooked mental health disparity among Indigenous North American people with HD – and the need for care grounded in trust, community partnership, and cultural understanding. Read more
Food for Thought: The Importance of Nutrition in Huntington’s Disease
⏱️8 min read | What if nutrition is one of the warning lights we should be checking earlier in Huntington’s disease? New research suggests simple nutrition measures may help identify when people with HD need extra support. Read more
EN 
ES 
IT 
DE 
FR 